DataArt Joins Biotechnology Association BIO Deutschland
Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.
BIO Deutschland is one of the most influential biotech associations in Europe, established to support and promote the development of an innovative economic sector based on modern biosciences. The Berlin-based association currently has over 285 members and is active in a broad range of events that aim to provide biotechnology with a platform for discussion and interaction.
With an established Life Sciences Practice and dedicated R&D group, DataArt has accumulated extensive knowledge and deep expertise in building cutting-edge technology solutions in drug discovery and clinical trials. DataArt’s clients include prominent life sciences companies, such as Charles River Laboratories, Novaseek Research, PSI CRO, and Cancer Research UK. Within the BIO Deutschland, DataArt’s team has joined the Bio-IT, Big Data & E-Health working group.
“Joining BIO Deutschland is a tremendous opportunity for DataArt, to share our experience, engage with other industry players, and collaborate on resolving challenges,” said Daniel Piekarz, Head of DataArt’s Healthcare and Life Sciences Practice. “We’re particularly excited to join the working group dedicated to Bio-IT, Big Data & E-Health as this is our area of expertise and we look forward to helping move the industry forward.”
This article has been republished from materials provided by DataArt. Note: material may have been edited for length and content. For further information, please contact the cited source.
Changing Lanes: Algorithm Helps AI Drive More Like HumansNews
For self-driving cars, algorithms for changing lanes are beset by one of two problems. Either, they rely on detailed statistical models of the driving environment, which are too complex to analyze on the fly; or they’re so simple that they can lead to impractically conservative decisions, such as never changing lanes at all. Now a new algorithm hopes to split the difference, allowing aggressive lane changes than the simple models do but relies only on immediate information about other vehicles’ directions and velocities to make decisions.
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
Tiny Particles Carry Tumor Shrinking Drugs into the BrainNews
MIT researchers have now devised a new drug-delivering nanoparticle that could offer a better way to treat glioblastoma. The particles, which carry two different drugs, are designed so that they can easily cross the blood-brain barrier and bind directly to tumor cells.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018